Actuate Therapeutics, Inc.
ACTU • XNAS • Stock Fundamentals
Actuate Therapeutics, Inc. is a pharmaceutical preparations company trading on XNAS, led by CEO Daniel Schmitt, with a market cap of $52.6M.
Market Cap$52.6M
CEODaniel Schmitt
CountryUnited States of America
PHARMACEUTICAL PREPARATIONS
Most Recent EarningsMay 14, 2026 · 14 days agoQ1 2026
View reportNext EarningsAug 13, 2026 · in 3 monthsQ2 2026
Financials
Based on Q1 2026 filing
Actuate Therapeutics, Inc. FAQ
Common questions about Actuate Therapeutics, Inc.
Actuate Therapeutics, Inc. (ACTU) has a market capitalization of $52.6M and trades on XNAS.